Welcome to PfizerEUPolicy

We partner with EU policymakers and stakeholders, driven by our purpose, breakthroughs that change patients’ lives.

Learn more about our team and vision to contribute to more pro-patient and pro-innovation policies in Europe.

Follow @PfizerEUPolicy on X to get our latest insights and real-time updates!

video_id
6355168894112
account_id
1852113022001
poster
title
Pfizer in EU

A More Competitive Europe

As a new mandate for the European Institutions begins, we reflect on a key challenge posed by today’s geopolitical landscape: the role of the European Union in an increasingly complex world, where global dynamics shift rapidly and new players emerge constantly.

In this landscape, we are exploring how to continue supporting patients and deliver breakthroughs that change people's lives.

Watch the video to learn more about our vision for a more competitive, innovative, and sustainable Europe.

Way back in 1849, Charles Pfizer and Charles Erhart started the company we know today as Pfizer, and ever since, we’ve been at the forefront of some of the most profound changes in medicine and technology. For 175 years, we have had an extraordinary impact on global health.

Innovating for a Healthier Future

Learn more about our recommendations for the upcoming institutional mandate.

Our Priorities

Resilience&Innovation

Pfizer’s global success relies on a stable, pro-innovation policy and a flexible, resilient supply chain.

Resilience and Innovation

Invested in Europe

With a presence in Europe since the 1950’s, Pfizer has invested significantly in our workforce and operations across the continent.

Invested In Europe

Access to Medicines

Ensuring equitable access to innovative treatments for patients across Europe is a common responsibility, as birthplace should not define access to care.

Access to Medicines

Industrial Policy

Putting a strong focus on competitiveness and industrial policy is a vital lesson Europe must learn from its recent challenges.

Industrial Policy

Inserting image...

Unmet Medical Needs

Defining and addressing unmet medical needs requires innovative solutions and collaboration to provide effective treatments where current options are lacking.

UMNs

Digital Health

Digital technologies are revolutionizing healthcare, enabling personalized patient care and optimizing the distribution of medicines.

Digital Health

Inserting image...

Supply Chains

Optimizing pharmaceutical supply chains is critical for ensuring timely access to medicines and bolstering healthcare resilience in the face of global challenges.

Supply Chains

Our ESG Commitment

As Pfizer marks 175 years, our strong ESG strategy drives long-term value and a sustainable, patient-focused business model.

Our ESG Commitment